Experts differ on whether regulation can prevent or accelerate change for financial services organizations and the technology ...

The new biotech Elevara plans to initiate Phase II testing of its lead candidate ELV001 as an add-on treatment for rheumatoid ...

Newly decoded brain circuits make memories more stable as part of learning, according to a study led by NYU Langone Health ...

The study shows that communication between the entorhinal cortex and the hippocampus’s CA3 region helps mice form stable maps of places.

Randomized trial data support the use of either TNF or IL-17 inhibitors to treat axial spondyloarthritis, based on patient ...

A new study reveals how brain circuits between the entorhinal cortex and hippocampus stabilize memories during learning.

"Lilly and Incyte to seek approval of alopecia JAK inhibitor in children" was originally created and published by Clinical ...

Discover Ardelyx's Q3 2025 earnings highlights: record IBSRELA growth, raised revenue guidance, new pipeline expansion, and strong long-term outlook.

A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous ...

The drug, which is an NLRP3 inhibitor, also reduced other key cardiovascular risk biomarkers. Ventyx Biosciences plans to ...

Neil Bressler, M.D., a professor of ophthalmology at Johns Hopkins and editor-in-chief of JAMA Ophthalmology, argued that complement inhibition for geographic atrophy is a game changer. His debating ...

Forward Therapeutics, Inc ('Forward”), a biotechnology company developing oral small molecule therapies for inflammation-driven diseases, today announced that the first participants have been dosed in ...